Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection

O'Donnell, Valerie B. ORCID: https://orcid.org/0000-0003-4089-8460, Thomas, David ORCID: https://orcid.org/0000-0001-7319-5820, Stanton, Richard ORCID: https://orcid.org/0000-0002-6799-1182, Maillard, Jean-Yves ORCID: https://orcid.org/0000-0002-8617-9288, Murphy, Robert C., Jones, Simon A. ORCID: https://orcid.org/0000-0001-7297-9711, Humphreys, Ian ORCID: https://orcid.org/0000-0002-9512-5337, Wakelam, Michael J. O., Fegan, Christopher ORCID: https://orcid.org/0000-0001-9685-0621, Wise, Matt P., Bosch, Albert and Sattar, Syed A. 2020. Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection. Function 1 (1) , zqaa002. 10.1093/function/zqaa002

PDF - Published Version Available under License Creative Commons Attribution. Download (611kB)

Abstract

Emerging studies increasingly demonstrate the importance of the throat and salivary glands as sites of virus replication and transmission in early COVID-19 disease. SARS-CoV-2 is an enveloped virus, characterized by an outer lipid membrane derived from the host cell from which it buds. While it is highly sensitive to agents that disrupt lipid biomembranes, there has been no discussion about the potential role of oral rinsing in preventing transmission. Here, we review known mechanisms of viral lipid membrane disruption by widely available dental mouthwash components that include ethanol, chlorhexidine, cetylpyridinium chloride, hydrogen peroxide, and povidone-iodine. We also assess existing formulations for their potential ability to disrupt the SARS-CoV-2 lipid envelope, based on their concentrations of these agents, and conclude that several deserve clinical evaluation. We highlight that already published research on other enveloped viruses, including coronaviruses, directly supports the idea that oral rinsing should be considered as a potential way to reduce transmission of SARS-CoV-2. Research to test this could include evaluating existing or specifically tailored new formulations in well-designed viral inactivation assays, then in clinical trials. Population-based interventions could be undertaken with available mouthwashes, with active monitoring of outcome to determine efficacy. This is an under-researched area of major clinical need.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy Medicine Systems Immunity Research Institute (SIURI)
Additional Information:	This is an Open Access article distributed under the terms of the Creative Commons Attribution License.
Publisher:	American Physiological Society
ISSN:	2633-8823
Date of First Compliant Deposit:	16 May 2020
Date of Acceptance:	14 May 2020
Last Modified:	04 May 2023 05:12
URI:	https://orca.cardiff.ac.uk/id/eprint/131759

Citation Data

Cited 79 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item